67 completed, 22 unknown, 11 terminated, 10 not yet recruiting. 130 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 130 | Completed 67, Unknown 22, Terminated 11, Not yet recruiting 10, Recruiting 7, Withdrawn 6, Active not recruiting 4, Enrolling by invitation 2, Suspended 1 |
Follow Wound Infection: new trials by email Literature Review of Wound Infection trials Research Report on Wound Infection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Investigation of the PREVENTIA® Irrigation Solution for Reducing Bacteria in Spinal Surgery With Implants - A Comparative Study Preventia Surgical Solution, 0.9 % NaCl - Surgical Site Infection (SSI), Spine Surgery | Phase 4 | Not yet recruiting | Universität Luzern | 114 | 2027-01-01 | 2026-06-29 |
| Antibiotic Tissue Penetration and Tissue Response in Head and Neck Infection and Reconstructive Surgery Cefuroxime, Dicloxacillin, Cloxacillin - Surgical Wound Infection, Neck Infection | Phase 4 | Recruiting | Tejs Ehlers Klug | 16 | 2026-11-01 | 2026-11-04 |
| Continuous Infusion Versus Intermittent IV Bolus of Cefazolin: Prevention of Surgical Site Infection During Orthopedic Surgeries in Egyptian Patients. Cefazolin 2 g Infusion, Cefazolin 2 GM Injection - Surgical Site Infection (SSI) | Phase 4 | Not yet recruiting | Helwan University | 100 | 2026-07-01 | 2026-06-24 |
| Continuous Infusion Versus Intermittent IV Bolus of Cefazolin: Prevention of Surgical Site Infection During CABG Surgeries in Egyptian Patients. Cefazolin 2 g Infusion, Cefazolin 2 GM Injection - Surgical Site Infection (SSI) | Phase 4 | Not yet recruiting | Helwan University | 100 | 2026-07-01 | 2026-06-24 |
| Gut Decolonisation With Neomycin/Metronidazole or Rifaximin Before Colon Surgery Rifaximin (Xifaxan), Metronidazole, Neomycin Sulfate - Surgical Site Infection, Colon Surgery | Phase 4 | Not yet recruiting | Universität Luzern | 458 | 2026-06-01 | 2025-09-18 |
| Innovative Sternal Closure Techniques: Evaluating STRATAFIX™ and DERMABOND™ for Reduced Complications in CABG Patients Knotless Barbed Sutures, Mesh-based Topical Skin Adhesive - Cardiovascular Disease, Surgical Site Infection | Phase 4 | Not yet recruiting | Unity Health Toronto | 401 | 2026-05-01 | 2026-04-13 |
| Efficacy and Cost-Effectiveness of Topical Vancomycin Powder in Preventing Pediatric Ventriculoperitoneal Shunt Infections Across Different Etiologies Topical Vancomycin Powder, Standard Perioperative Care - Hydrocephalus, Ventriculoperitoneal Shunt Infection | Phase 4 | Not yet recruiting | Assiut University | 164 | 2026-05-01 | 2026-04-23 |
| Prevention of Infections in Cardiac Surgery (PICS): a Cluster-randomized Factorial Cross-over Trial Cefazolin, Vancomycin - Infection, Surgical Site | Phase 4 | Not yet recruiting | Hamilton Health Sciences Corporation | 38000 | 2026-03-01 | 2026-03-12 |
| Preoperative Clindamycin Vaginal Cream Versus Vaginal Cleansing With Povidone-iodine on Postoperative Infections After Cesarean Section Clindamycin vaginal cream, Vaginal preparation with povidone- iodide solution 10 % - Infection Control / Methods, Surgical Site Infection (SSI) | Phase 4 | Recruiting | Beni-Suef University | 150 | 2025-09-20 | 2026-03-16 |
| Probiotics in the Prevention of Recurrent Prosthetic Joint Infection of the Hip and Knee Probiotic, Standard of care - Prosthetic-joint Infection, Dysbiosis | Phase 4 | Enrolling by invitation | Boston Medical Center | 152 | 2025-08-15 | 2026-08-26 |
| PRevention Of Trauma-related Infections Through an Embedded Clinical Trials Network Ertapenem, Cefazolin and Metronidazole. - Surgical Site Infection | Phase 4 | Not yet recruiting | The University of Texas Health Science Center, Houston | 300 | 2025-05-01 | 2025-04-11 |
| Impact of Probiotics on Gut Microbiome During Antibiotic Prophylaxis in Elective Orthopedic Surgery Placebo Capsule, Probiotic with Human Milk Oligosaccharides (HMO) - Dysbiosis, Gut -microbiota | Phase 4 | Not yet recruiting | Acibadem Maslak Hospital | 60 | 2025-02-01 | 2025-01-24 |
| Powdered Intrawound Vancomycin in Open Fractures Trial Vancomycin 1000 MG - Open Fracture, Trauma | Phase 4 | Not yet recruiting | University of Manitoba | 350 | 2024-11-01 | 2024-09-19 |
| Irrisept in Emergency General Surgery Patients Chlorhexidine, Normal Saline - Emergency Surgery, Surgical Site Infections | Phase 4 | Enrolling by invitation | The University of Texas Health Science Center at Tyler | 400 | 2024-09-04 | 2025-07-03 |
| The Role of Postoperative Antibiotics in Laparoscopic Cholecystectomy IV antibiotic, Oral antibiotic - Infection Wound, Antibiotic Resistant Infection | Phase 4 | Unknown | Minia University Hospital | 300 | 2024-08-30 | 2024-09-23 |
| Prophylactic Antibiotics for Surgical Site Infections and Beta-Lactam Allergy cephalosporin, Second tier antibiotic (Vancomycin) - Surgical Site Infection, Beta-lactam Allergy | Phase 4 | Withdrawn | University of Texas Southwestern Medical Center | 2024-08-16 | 2023-12-15 | |
| Polihexanide SSIs Measures Bundle (PSMB) During Enhanced Recovery After Major Digestive Surgery Polihexanide-based bundle, Standard bundle - Surgical Site Infection, Surgical Procedures, Operative | Phase 4 | Unknown | Marco Catarci | 2000 | 2024-07-01 | 2024-04-04 |
| Prophylactic Effects for Preventing Surgical Site Infection in Third Molar Surgery Ampicillin - Surgical Site Infection | Phase 4 | Completed | Uji Takeda Hospital | 70 | 2024-05-02 | 2025-09-24 |
| Ostomy Primary Closure With 0.1% Betaine/Polyhexanide Wound Irrigation Compared to Pursestring Closure Primary Ostomy Closure with 0.1% Betaine/0.1% Polyhexanide Wound Irrigation, Pursestring Closure - Surgical Site Infection, Wound Surgical | Phase 4 | Recruiting | University of Nevada, Las Vegas | 84 | 2024-03-14 | 2025-06-02 |
| Effectiveness of Postoperative Topical and Oral Antibiotics on Impacted Mandibular 3rd Molar Surgery. Topical Antibiotic, Oral antibiotic therapy - Impacted Tooth, Postoperative Complications in Maxillofacial Surgery | Phase 4 | Completed | Liaquat College of Medicine and Dentistry | 90 | 2024-02-01 | 2026-05-12 |
Showing 20 of 130. Sign in to see all of them.
Surgical Wound Infection (106) · Infections (11) · Fractures, Open (5) · Postoperative Complications (4) · Surgical Wound (4) · Wounds and Injuries (4) · Bacterial Infections (2) · Burns (2) · Dysbiosis (2) · Endometritis (2) · Hemorrhage (2) · Obesity (2) · Pain (2) · Pneumonia (2)
Infections (119) · Pathological Conditions, Signs and Symptoms (113) · Pathologic Processes (111) · Postoperative Complications (104) · Wounds and Injuries (10) · Bacterial Infections and Mycoses (6) · Signs and Symptoms (6) · Fractures, Bone (5) · Bacterial Infections (4) · Digestive System Diseases (4) · Neoplasms (4) · Neoplasms by Site (4) · Skin and Connective Tissue Diseases (4) · Digestive System Neoplasms (3)
Cefazolin (18) · Vancomycin (12) · Cefuroxime (11) · Metronidazole (9) · Clindamycin (8) · Povidone-Iodine (7) · Saline Solution (6) · chlorhexidine gluconate (6) · Amoxicillin-Potassium Clavulanate Combination (5) · Anti-Bacterial Agents (5) · Standard of Care (5) · Chlorhexidine (4) · Polyglactin 910 (4) · Sodium Chloride (4) · Triclosan (4)
Assiut University (2) · ClinAmygate (2) · Georgetown University (2) · Helwan University (2) · Odense University Hospital (2) · Ottawa Hospital Research Institute (2) · Rabin Medical Center (2) · The University of Texas Health Science Center, Houston (2) · The University of Texas Medical Branch, Galveston (2) · University Hospital, Basel, Switzerland (2) · University of Maryland, Baltimore (2) · University of Tennessee (2) · Universität Luzern (2) · Abdul El-Rabbany (1) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1)
United States (49) · Canada (10) · Egypt (8) · Switzerland (7) · Italy (6) · Israel (4) · Spain (4) · Sweden (4) · Denmark (3) · Netherlands (3) · Australia (2) · Austria (2) · France (2) · Taiwan (2) · Turkey (Türkiye) (2)
Christopher Attinger, MD (2) · Emad R Issak, Diploma (2) · Gerard Slobogean, MD (2) · Mohit Bhandari, MD (2) · Sheila Sprague, PhD (2) · Abel Wakai, MD FRCEM (1) · Adrian Moughty (1) · Ahmed Dr El Kased, PhD (1) · Alan G Smulian, M.B.B.Ch. (1) · Alex Bekker, MD/PhD (1) · Ali Husain, MD (1) · Allison R Lauver, PharmD (1) · Amyntas Varvaroussis, MD (1) · Anders Jeppsson, MD PhD (1) · Andrea Milillo, Dr. (1)
PMID 40260835, PMID 41159585, PMID 31481559, PMID 32259266, PMID 32787892, PMID 36748942, PMID 10219875, PMID 11294711, PMID 12439804, PMID 12603990, PMID 12963381, PMID 15273542, PMID 15613293, PMID 15620935, PMID 15909433, PMID 1656747, PMID 17235400, PMID 17883362, PMID 17932825, PMID 18655991, PMID 18957455, PMID 19281889, PMID 19376733, PMID 1951905, PMID 19638912, PMID 21118502, PMID 21412147, PMID 22083832, PMID 23435526, PMID 23743467, PMID 24745317, PMID 24885132, PMID 24915210, PMID 25129595, PMID 25175629, PMID 25637469, PMID 26090835, PMID 26170157, PMID 26432552, PMID 27106640, PMID 28385346, PMID 2868173, PMID 28796687, PMID 28836993, PMID 29279933, PMID 29408507, PMID 29553001, PMID 29568771, PMID 29704562, PMID 30019145
2014 (1), 2018 (1), 2025 (1), U54CK000613 (1)